Jarushka Naidoo, MB BCH - Memorial Sloan Kettering Cancer Center - Medical Oncology Fellow

Jarushka Naidoo

MB BCH

Memorial Sloan Kettering Cancer Center

Medical Oncology Fellow

New York, NY | United States

Main Specialties: Oncology

Additional Specialties: Medical Oncology

Jarushka Naidoo, MB BCH - Memorial Sloan Kettering Cancer Center - Medical Oncology Fellow

Jarushka Naidoo

MB BCH

Introduction

Primary Affiliation: Memorial Sloan Kettering Cancer Center - New York, NY , United States

Specialties:

Additional Specialties:

Publications

5Publications

157Reads

-Profile Views

60PubMed Central Citations

Differences in the survival of patients with recurrent versus de novo metastatic KRAS-mutant and EGFR-mutant lung adenocarcinomas.

Cancer 2015 Jun 17;121(12):2078-82. Epub 2015 Mar 17.

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29313DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783794PMC
June 2015
41 Reads
5 Citations
4.890 Impact Factor

Emerging immunotherapy strategies in breast cancer.

Immunotherapy 2014 ;6(2):195-209

Memorial Sloan-Kettering Cancer Center, Department of Medicine, 300 East 66th Street, New York, NY 10065, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt.13.166DOI Listing
October 2014
7 Reads
6 Citations
2.440 Impact Factor

Immune checkpoint blockade.

Hematol Oncol Clin North Am 2014 Jun;28(3):585-600

Melanoma and Immunotherapy Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA; Ludwig Center for Cancer Immunotherapy, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2014.02.002DOI Listing
June 2014
25 Reads
10 Citations
2.295 Impact Factor

Pretreatment serum VEGF is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumab.

Cancer Immunol Res 2014 02;2(2):127-32

Authors' Affiliations Melanoma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-13-0163DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991109PMC
February 2014
61 Reads
31 Citations

Should patients with extrapulmonary small-cell carcinoma receive prophylactic cranial irradiation?

J Thorac Oncol 2013 Sep;8(9):1215-21

Department of Medical Oncology, Waterford Regional Hospital, Waterford, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31829f6b03DOI Listing
September 2013
23 Reads
8 Citations
5.282 Impact Factor

Top co-authors

David B Page
David B Page

Northwestern University Feinberg School of Medicine

3
Jedd D Wolchok
Jedd D Wolchok

Memorial Sloan Kettering Cancer Center

2
Xinqi Wu
Xinqi Wu

Dana-Farber Cancer Institute and Harvard Medical School

1
Philip Wong
Philip Wong

The Johns Hopkins University School of Medicine

1
Katherine S Panageas
Katherine S Panageas

New York University School of Medicine

1
Heather L McArthur
Heather L McArthur

and Vancouver General Hospital

1
Paula Calvert
Paula Calvert

Newcastle General Hospital

1
Harry Comber
Harry Comber

National Cancer Registry

1
Sandra Deady
Sandra Deady

Waterford Regional Hospital

1
Min Yuen Teo
Min Yuen Teo

Waterford Regional Hospital

1